NR3C1
Glucocorticoid receptor
Also known as: GCR_HUMAN, GR, GRL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04150
- Gene
- NR3C1
- Ensembl
- ENSG00000113580
- Chromosome
- 5
- Canonical length
- 777 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Mitochondria,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
777 residues, UniProt reviewed canonical sequence.
>P04150|NR3C1
1 MDSKESLTPG REENPSSVLA QERGDVMDFY KTLRGGATVK VSASSPSLAV ASQSDSKQRR
61 LLVDFPKGSV SNAQQPDLSK AVSLSMGLYM GETETKVMGN DLGFPQQGQI SLSSGETDLK
121 LLEESIANLN RSTSVPENPK SSASTAVSAA PTEKEFPKTH SDVSSEQQHL KGQTGTNGGN
181 VKLYTTDQST FDILQDLEFS SGSPGKETNE SPWRSDLLID ENCLLSPLAG EDDSFLLEGN
241 SNEDCKPLIL PDTKPKIKDN GDLVLSSPSN VTLPQVKTEK EDFIELCTPG VIKQEKLGTV
301 YCQASFPGAN IIGNKMSAIS VHGVSTSGGQ MYHYDMNTAS LSQQQDQKPI FNVIPPIPVG
361 SENWNRCQGS GDDNLTSLGT LNFPGRTVFS NGYSSPSMRP DVSSPPSSSS TATTGPPPKL
421 CLVCSDEASG CHYGVLTCGS CKVFFKRAVE GQHNYLCAGR NDCIIDKIRR KNCPACRYRK
481 CLQAGMNLEA RKTKKKIKGI QQATTGVSQE TSENPGNKTI VPATLPQLTP TLVSLLEVIE
541 PEVLYAGYDS SVPDSTWRIM TTLNMLGGRQ VIAAVKWAKA IPGFRNLHLD DQMTLLQYSW
601 MFLMAFALGW RSYRQSSANL LCFAPDLIIN EQRMTLPCMY DQCKHMLYVS SELHRLQVSY
661 EEYLCMKTLL LLSSVPKDGL KSQELFDEIR MTYIKELGKA IVKREGNSSQ NWQRFYQLTK
721 LLDSMHEVVE NLLNYCFQTF LDKTMSIEFP EMLAEIITNQ IPKYSNGNIK KLLFHQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR3C1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 47 nTPM
- placenta: 44 nTPM
- skeletal muscle: 42 nTPM
- tongue: 38 nTPM
- thymus: 37 nTPM
- liver: 37 nTPM
Single-cell type
- corticotrophs: 1,169 nCPM
- neutrophils: 1,012 nCPM
- pdcs: 862 nCPM
- myonuclei: 692 nCPM
- somatotrophs: 644 nCPM
- t-cells: 604 nCPM
Immune cell
- neutrophil: 69 nTPM
- basophil: 68 nTPM
- eosinophil: 39 nTPM
- myeloid DC: 29 nTPM
- plasmacytoid DC: 26 nTPM
- intermediate monocyte: 24 nTPM
Brain region
- cerebellum: 82 nTPM
- white matter: 72 nTPM
- hypothalamus: 65 nTPM
- cerebral cortex: 63 nTPM
- thalamus: 59 nTPM
- choroid plexus: 51 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NR3C1.
Disease | AllUniProt
Conditions NR3C1 is implicated in, by any mechanism.
- Glucocorticoid resistance, generalized (GCCR) MIM:615962
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 331 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Glucocorticoid resistance
- GLUCOCORTICOID RESISTANCE, CELLULAR
- GLUCOCORTICOID RESISTANCE, ATYPICAL
- Deficiency of galactokinase
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.84
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adrenal gland development
- apoptotic process
- astrocyte differentiation
- cell division
- cellular response to dexamethasone stimulus
- cellular response to glucocorticoid stimulus
- cellular response to steroid hormone stimulus
- cellular response to transforming growth factor beta stimulus
- chromatin organization
- chromosome segregation
- gene expression
- glucocorticoid metabolic process
- mammary gland duct morphogenesis
- maternal behavior
- microglia differentiation
- motor behavior
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- neuroinflammatory response
- nuclear receptor-mediated steroid hormone signaling pathway
- positive regulation of miRNA transcription
- positive regulation of neuron apoptotic process
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- regulation of gluconeogenesis
- regulation of transcription by RNA polymerase II
- response to cortisol
- response to wounding
- signal transduction
- synaptic transmission, glutamatergic
- regulation of glucocorticoid biosynthetic process
Molecular functions
- core promoter sequence-specific DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- estrogen response element binding
- Hsp90 protein binding
- identical protein binding
- nuclear receptor activity
- promoter-specific chromatin binding
- protein kinase binding
- RNA binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- steroid binding
- steroid hormone binding
- TBP-class protein binding
- zinc ion binding
- nuclear glucocorticoid receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Zinc finger, NHR/GATA-type
- Nuclear hormone receptor-like domain superfamily
- Nuclear hormone receptor family NR3 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
- Glucocorticoid receptor
- Glucocorticoid receptor
KeywordsUniProt
- Acetylation
- Alternative initiation
- Apoptosis
- Cell cycle
- Cell division
- Chromatin regulator
- Chromosome
- Chromosome partition
- Cytoplasm
- Cytoskeleton
- DNA-binding
- Isopeptide bond
- Lipid-binding
- Metal-binding
- Methylation
- Mitochondrion
- Mitosis
- Nucleus
- Phosphoprotein
- Pseudohermaphroditism
- Receptor
- RNA-binding
- Steroid-binding
- Transcription
- Transcription regulation
- Ubl conjugation
- Zinc
- Zinc-finger
InteractionsUniProt · HPA
Protein binding partners of NR3C1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR3C1 as an antibody target. Whether an autoantibody or antibody against NR3C1 could matter depends on whether native NR3C1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR3C1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR3C1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...